title: Does deflux alter the paradigm for the management of children with vesicoureteral reflux?
abstract: The recent approval by the US Food and Drug Administration of Deflux (Q Med, Uppsala, Sweden), a particulate biodegradable polymer of dextran, has led to an understandable enthusiasm for treating children with vesicoureteral reflux by a routinely simple outpatient endoscopic procedure. However, Deflux is but one of a variety of particulate substances, both permanent and absorbable, that have been used to treat reflux in Europe for well over a decade with varying degrees of success. The purpose of this review is to place Deflux in this wider context to anticipate what can be expected realistically regarding the efficacy and potential hazards of this seductive technique and to make recommendations regarding its incorporation, in selected cases, in our therapeutic armamentarium.
authors.affiliation: Medical University of South Carolina, Clinical Science Building, 96 Jonathan Lucas Street, Room 644, P.O. Box 250620, Charleston, SC 29425, USA. aaronson@musc.edu
authors.forename: Ian A
authors.initials: IA
authors.lastname: Aaronson
mesh_terms: D002675:Child, Preschool; D003911:Dextrans / Q000627:therapeutic use*; D004724:Endoscopy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006820:Hyaluronic Acid / Q000627:therapeutic use*; D007223:Infant; D015552:Injections, Intralesional; D008297:Male; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome; D018666:Ureteroscopy / Q000379:methods; D014563:Urodynamics; D014718:Vesico-Ureteral Reflux / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D003911:Dextrans; C094535:deflux; D006820:Hyaluronic Acid
references.citation: J Urol. 2003 Oct;170(4 Pt 2):1541-4; discussion 1544
references.pmid: 14501655
references.citation: J Urol. 2001 Nov;166(5):1887-92
references.pmid: 11586255
references.citation: Br Med J (Clin Res Ed). 1984 Jul 7;289(6436):7-9
references.pmid: 6428669
references.citation: J Urol. 1992 Aug;148(2 Pt 2):718-23
references.pmid: 1640554
references.citation: J Urol. 1997 Nov;158(5):1937-41
references.pmid: 9334643
references.citation: J Urol. 1993 Aug;150(2 Pt 2):694-6
references.pmid: 8326625
references.citation: JAMA. 1984 Jun 22-29;251(24):3277-81
references.pmid: 6374180
references.citation: Eur Urol. 1993;23(3):394-9
references.pmid: 8508896
references.citation: J Urol. 2003 Apr;169(4):1480-4; discdussion 1484-5
references.pmid: 12629396
references.citation: Arch Dermatol. 1993 Jan;129(1):63-8
references.pmid: 8420493
references.citation: Arch Otolaryngol. 1967 Nov;86(5):562-7
references.pmid: 4952843
references.citation: J Urol. 2003 Oct;170(4 Pt 2):1556-8; discussion 1559
references.pmid: 14501659
references.citation: J Urol. 2003 Mar;169(3):1109-13
references.pmid: 12576864
references.citation: J Urol. 1991 Jan;145(1):115-9
references.pmid: 1898520
references.citation: Arch Pathol Lab Med. 1983 Nov;107(11):611-2
references.pmid: 6688722
references.citation: J Urol. 1987 Oct;138(4 Pt 2):950-2
references.pmid: 3656577
references.citation: J Urol. 1995 Aug;154(2 Pt 2):800-3
references.pmid: 7541869
references.citation: Acta Paediatr Suppl. 1999 Nov;88(431):62-71
references.pmid: 10588273
references.citation: J Urol. 1995 Jun;153(6):2039-43
references.pmid: 7752390
references.citation: Eur Urol. 1990;17(4):328-9
references.pmid: 2194818
references.citation: J Urol. 2003 Jul;170(1):211-5
references.pmid: 12796692
references.citation: J Urol. 2004 Oct;172(4 Pt 2):1614-6
references.pmid: 15371773
references.citation: J Urol. 1989 Sep;142(3):821-2
references.pmid: 2671416
references.citation: J Urol. 1991 Aug;146(2):319-22
references.pmid: 1856925
references.citation: J Urol. 1984 Sep;132(3):463-4
references.pmid: 6471177
references.citation: Contemp Urol. 1991 Dec;3(12):40-3
references.pmid: 10148057